Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR) a double-blind, placebo-controlled, randomised, phase 3 trial /

Butler Javed, McMullan Ciaran J, Anstrom Kevin J, Barash Irina, Bonaca Marc P, Borentain Maria, Corda Stefano, Ezekowitz Justin A, Felker G Michael, Gates Davis, Lam Carolyn S P, Lewis Eldrin F, Lindenfeld JoAnn, Mentz Robert J, O'Connor Christopher M, et al, Kollaborációs szervezet: VICTOR Study Group, Habon Tamás, Thury Attila, Kalapos Anita, Kormányos Árpád
2025